Cancer Screening Insights

Breast and Colon Cancer Screenings and Diagnoses 

LexisNexis® Risk Solutions analyzed de-identified medical claims from LexisNexis® MarketView™ to uncover the latest trends in breast cancer and colon cancer screenings from 2021 to 2023. This brief also examines the increases in both breast and colon cancer diagnoses.

Download the brief to Reveal: 

• How overall breast and colon cancer screening and diagnosis rates trended from 2021 to 2023 
• A notable increase in breast cancer diagnoses and screenings among patients in their 30s and patients over 70
• How colonoscopies across all age groups have risen
• Increases in utilization of alternatives to colonoscopies in recent years  

Why is this important?

As screening guidance evolves, there is a need for healthcare leaders to continuously monitor the population using timely data to evaluate any behavior changes stemming from updated recommendations on cancer screenings. Data-informed population health monitoring can also provide insight into health disparities among groups with limited access to care. There is also significant potential to advance screening compliance through innovation, such as increasing the variety of screening modalities and patient engagement tools.